Literature DB >> 1894470

Analysis of immunosuppressive properties of iris and ciliary body cells and their secretory products.

J W Streilein1, D Bradley.   

Abstract

The anterior chamber of the eye is an immunosuppressive microenvironment as shown experimentally by immune privilege, anterior chamber-associated immune deviation, and inability to display local delayed-type hypersensitivity responses. It recently was reported that both the aqueous humor and the cells of the iris and ciliary body (I-CB) have immune inhibitory properties in vitro, suggesting that these components of the anterior segment might contribute to the unique properties of this microenvironment. To explore the cellular sources of immunosuppressive factors in the anterior chamber, cultures of I-CB cells were established from normal eyes of BALB/c mice. Supernatants were harvested from these cultures and assayed in vitro for their ability to inhibit T-lymphocyte activation. It was found that I-CB cell-derived supernatants profoundly suppressed alloantigen-driven T-cell proliferation (mixed lymphocyte response) and interleukin-2 production by a T-cell hybridoma that responds to stimulator cells bearing I-Ad. The inhibitory activity of I-CB supernatants did not appear to be related to prostaglandins; supernatants of I-CB cells cultured with indomethacin retained their suppressive properties, as did supernatants to which neutralizing antiprostaglandin E2 antibodies had been added. Moreover, suppression by I-CB supernatants was not relieved by antibodies specific for transforming growth factor-beta, even though this cytokine is known to be present in normal aqueous humor. Thus, the identity of the suppressive factor(s) in cultured I-CB cell supernatants remains elusive. Finally, by separating I-CB cell suspensions into bone marrow-derived (T-200-positive) and those not derived from bone marrow (parenchymal) subpopulations with a fluorescence-activated cell sorter, it was determined that the inhibitory activity of I-CB cell suspensions was produced by parenchymal, rather than hematogenous, cells. It is proposed and discussed that inhibitory factors and cytokines secreted by parenchymal I-CB cells contribute to the immunosuppressive qualities of the anterior chamber.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1894470

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  12 in total

Review 1.  Translational Immunoimaging and Neuroimaging Demonstrate Corneal Neuroimmune Crosstalk.

Authors:  Pedram Hamrah; Yashar Seyed-Razavi; Takefumi Yamaguchi
Journal:  Cornea       Date:  2016-11       Impact factor: 2.651

2.  The influence of penetrating keratoplasty and cyclosporin A therapy on MHC class II (Ia)-positive cells in the rat iris and choroid.

Authors:  S E Coupland; L Krause; F Hoffmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-02       Impact factor: 3.117

3.  Inhibition of fibroblast proliferation by human iris pigment epithelial cells in vitro: preliminary results.

Authors:  Z J Fan; H R Wei; A Wang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-01       Impact factor: 3.117

4.  Abrogating TNF-α expression prevents bystander destruction of normal tissues during iNOS-mediated elimination of intraocular tumors.

Authors:  Terry G Coursey; Peter W Chen; Jerry Y Niederkorn
Journal:  Cancer Res       Date:  2011-02-09       Impact factor: 12.701

5.  Transplantation of cultured human retinal pigment epithelium into rabbit subretina.

Authors:  S He; H M Wang; T E Ogden; S J Ryan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-12       Impact factor: 3.117

6.  Functional studies of major histocompatibility class II-positive dendritic cells and resident tissue macrophages isolated from the rat iris.

Authors:  R J Steptoe; P G Holt; P G McMenamin
Journal:  Immunology       Date:  1995-08       Impact factor: 7.397

7.  CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site.

Authors:  K H Sonoda; M Exley; S Snapper; S P Balk; J Stein-Streilein
Journal:  J Exp Med       Date:  1999-11-01       Impact factor: 14.307

8.  Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential.

Authors:  Qiuhong Li; Rehae Miller; Ping-Yang Han; Jijing Pang; Astra Dinculescu; Vince Chiodo; William W Hauswirth
Journal:  Mol Vis       Date:  2008-09-24       Impact factor: 2.367

9.  Gene therapy following subretinal AAV5 vector delivery is not affected by a previous intravitreal AAV5 vector administration in the partner eye.

Authors:  Wensheng Li; Fansheng Kong; Xia Li; Xufeng Dai; Xiaoqiang Liu; Qinxiang Zheng; Ronghan Wu; Xiangtian Zhou; Fan Lü; Bo Chang; Qiuhong Li; William W Hauswirth; Jia Qu; Ji-Jing Pang
Journal:  Mol Vis       Date:  2009-02-06       Impact factor: 2.367

10.  Iris pigment epithelium expressing CD86 (B7-2) directly suppresses T cell activation in vitro via binding to cytotoxic T lymphocyte-associated antigen 4.

Authors:  Sunao Sugita; J Wayne Streilein
Journal:  J Exp Med       Date:  2003-06-30       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.